Boxed Warning Added to Promethazine Labeling for Pediatric Use
Authors:
- Peter R. StarkePSPeter R. Starke
- Joyce WeaverJWJoyce Weaver
- Badrul A. ChowdhuryBCBadrul A. Chowdhury
- 23 June 2005
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (25) , 2653
Abstract
In late 2004, a “boxed warning” was added to the labeling for promethazine hydrochloride (Phenergan), including a contraindication for use in children less than two years of age and a strengthened warning with regard to use in children two years of age or older. We describe the basis for this action.Keywords
This publication has 3 references indexed in Scilit: